Polypeptide antibiotic 26a from Bacillus subtilis. IV. Evaluation of biological in vivo activity

Jarosz, J.; Gliński, Z.

Acta Microbiologica Polonica 27(4): 375-381

1978


ISSN/ISBN: 0137-1320
PMID: 86285
Document Number: 131291
The studies performed with the antibiotic 26a, which has a close resemblance to bacitracin family polypeptide antibiotics, revealed a prominent therapeutic and protective actions. The antibiotic is characterized by a moderately low toxicity, lack of cytotoxic and cytostatic effects on several tissue cultures, and therapeutic effectiveness in lethal streptococcal infections in mice, and corynebacterial infections in guinea pigs.

Document emailed within 1 workday
Secure & encrypted payments